FORLANI, GRETA
 Distribuzione geografica
Continente #
NA - Nord America 743
EU - Europa 153
AS - Asia 64
AF - Africa 5
SA - Sud America 3
Totale 968
Nazione #
US - Stati Uniti d'America 734
IT - Italia 67
FR - Francia 29
CN - Cina 28
DE - Germania 27
VN - Vietnam 21
CA - Canada 9
RU - Federazione Russa 6
ZA - Sudafrica 5
FI - Finlandia 4
IE - Irlanda 4
IN - India 4
NL - Olanda 4
CL - Cile 3
JP - Giappone 3
KR - Corea 3
UA - Ucraina 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
GB - Regno Unito 2
HK - Hong Kong 2
AT - Austria 1
BE - Belgio 1
BY - Bielorussia 1
GR - Grecia 1
IR - Iran 1
SE - Svezia 1
Totale 968
Città #
Fairfield 119
Woodbridge 69
Seattle 59
Ashburn 50
Buffalo 50
Houston 45
Santa Cruz 36
Cambridge 33
Wilmington 19
Como 16
Ann Arbor 14
Dong Ket 14
Chicago 13
Shanghai 10
Beijing 8
Boardman 8
Milan 8
University Park 8
Magnago 7
Las Vegas 6
Ottawa 6
Phoenix 6
San Diego 6
San Francisco 6
Henderson 5
Los Angeles 5
Ponte Lambro 5
Dublin 4
Riva 4
Robbiate 4
Saint Petersburg 4
Wuhan 4
Council Bluffs 3
Fleming Island 3
Frankfurt am Main 3
Helsinki 3
Lake Forest 3
Muizenberg 3
New York 3
Amsterdam 2
Auburn 2
Bangalore 2
Brooklyn 2
Büdelsdorf 2
Easton 2
Ferrara di Monte Baldo 2
Genoa 2
Herndon 2
Nizhniy Novgorod 2
Norwalk 2
Portland 2
San Jose 2
Santa Clara 2
Scranton 2
Silverton 2
Tokyo 2
Torino 2
Bochum 1
Bologna 1
Bonn 1
Cedar Knolls 1
Cedar Park 1
Cernusco 1
Clearwater 1
Crugers 1
Denver 1
Edinburgh 1
Elkhart 1
Fremont 1
Glenview 1
Grenoble 1
Hangyang 1
Indiana 1
Jersey City 1
Jinan 1
Kashan 1
Leuven 1
Lombard 1
Ludwigshafen 1
Mainz 1
Margherita Di Savoia 1
Miami 1
Minsk 1
Moncalieri 1
Montréal 1
Monza 1
Mountain View 1
Nürnberg 1
Omaha 1
Padova 1
Paris 1
Philadelphia 1
Piscataway 1
Pohang 1
Providence 1
Redmond 1
Rozzano 1
Saint Cloud 1
San Pablo 1
Seoul 1
Totale 751
Nome #
Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model., file e2188be5-ff56-4564-e053-6605fe0a49d6 177
Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication, file e2188be5-fe84-4564-e053-6605fe0a49d6 135
The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators, file e2188be6-02e1-4564-e053-6605fe0a49d6 129
Boosting the MHC class II-restricted tumor antigen presentation to CD4+ T helper cells: A critical issue for triggering protective immunity and re-orienting the tumor microenvironment toward an anti-tumor state, file e2188be6-0468-4564-e053-6605fe0a49d6 127
The MHC-II transactivator CIITA, a viral restriction factor inhibiting the replication of Human T cell Lymphotropic virus type 1., file e2188be6-00ef-4564-e053-6605fe0a49d6 109
MHC class II transactivator CIITA inhibits Tax-2-mediated HTLV-2 LTR transactivation and viral replication by binding to and affecting Tax-2 intracellular localization, file e2188be6-00f0-4564-e053-6605fe0a49d6 108
Functional consequences of mutations in CDKL5, an X-linked gene involved in infantile spasms and mental retardation, file e2188be6-013d-4564-e053-6605fe0a49d6 103
Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine, file 0ad152cb-b7e3-40ad-ab7d-ab8a0f9ccda2 38
Reply to the Letter to the Editor: “Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine” by Francavilla B et al.: Lack of a strong oral mucosal immune response: rethinking the route of COVID-19 vaccine boost administration?, file e2188be8-3241-4564-e053-6605fe0a49d6 24
Safety and immunogenicity of synchronous COVID19 and influenza vaccination, file e2188be8-38f3-4564-e053-6605fe0a49d6 15
HTLV-1 HBZ viral protein: A key player in HTLV-1 mediated diseases, file e2188be6-e6fa-4564-e053-6605fe0a49d6 6
Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells, file d407626e-e3b7-4817-9fe7-9ebea94fe773 5
Tripartite motif 22 and class II transactivator restriction factors: Unveiling their concerted action against retroviruses, file e2188be6-e33c-4564-e053-6605fe0a49d6 5
Humoral and cellular immune response elicited by the BNT162b2 COVID-19 vaccine booster in elderly, file 8333ed6f-d1b6-4442-b7f0-9cf026460c48 4
Reversible Human Immunodeficiency Virus Type-1 Latency in Primary Human Monocyte-Derived Macrophages Induced by Sustained M1 Polarization, file e2188be7-1152-4564-e053-6605fe0a49d6 4
The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells, file e2188be6-6918-4564-e053-6605fe0a49d6 3
The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-kappa B by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein, file e2188be6-6b0d-4564-e053-6605fe0a49d6 3
Cytoplasmic Localization of HTLV-1 HBZ Protein: A Biomarker of HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP), file e2188be6-c595-4564-e053-6605fe0a49d6 3
Multi-omics discovery of exome-derived neoantigens in hepatocellular carcinoma, file e2188be7-2da9-4564-e053-6605fe0a49d6 3
Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies against the glioblastoma, file ef533bcd-a852-4559-90a0-f6bc84650236 3
Three kinds of currents in the canine betaine-GABA transporter BGT-1 expressed in Xenopus laevis oocytes, file e2188be6-0134-4564-e053-6605fe0a49d6 1
Modulation of the inward rectifier potassium channel IRK1 by the Ras signaling pathway, file e2188be6-0136-4564-e053-6605fe0a49d6 1
The MHC-II transactivator CIITA inhibits Tat-mediated HIV-1 LTR transactivation and virus replication in human U937 monocytic cells, file e2188be6-0195-4564-e053-6605fe0a49d6 1
Molecular and Cellular Correlates of the CIITA-Mediated Inhibition of HTLV-2 Tax-2 Transactivator Function Resulting in Loss of Viral Replication., file e2188be6-0287-4564-e053-6605fe0a49d6 1
CIITA-driven MHC class ii expressing tumor cells can efficiently prime naive CD4+ TH cells in vivo and vaccinate the host against parental MHC-II-negative tumor cells, file e2188be6-c0d5-4564-e053-6605fe0a49d6 1
Totale 1.009
Categoria #
all - tutte 2.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019103 0 0 0 0 0 0 0 0 7 19 43 34
2019/2020236 23 15 23 39 18 20 18 18 25 10 11 16
2020/2021162 6 12 14 16 16 9 24 14 11 7 14 19
2021/2022187 18 27 1 5 17 8 8 8 7 15 51 22
2022/2023158 4 11 43 23 17 10 4 13 5 8 13 7
2023/202495 7 3 4 10 20 6 16 22 7 0 0 0
Totale 1.009